| Disparities in germline testing among racial minorities with prostate cancer N Weise, J Shaya, J Javier-Desloges, HH Cheng, L Madlensky, ... Prostate cancer and prostatic diseases 25 (3), 403-410, 2022 | 30 | 2022 |
| Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors PV Nuzzo, E Adib, N Weise, C Curran, T Stewart, D Freeman, AH Nassar, ... Clinical genitourinary cancer 20 (4), 301-306, 2022 | 12 | 2022 |
| Real-world practice patterns and safety of concurrent radiotherapy and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell … CL Gan, J Huang, E Pan, W Xie, AL Schmidt, C Labaki, L Meza, ... European Urology Oncology 6 (2), 204-211, 2023 | 7 | 2023 |
| Prognostic significance of pancreatic metastases in patients with advanced renal cell carcinoma treated with systemic therapy JA Shaya, X Lin, N Weise, A Cabal, J Panian, IH Derweesh, RR McKay Clinical Genitourinary Cancer 19 (6), e367-e373, 2021 | 6 | 2021 |
| Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective study C Duarte, J Hu, B Beuselinck, J Panian, N Weise, N Dizman, KA Collier, ... EClinicalMedicine 60, 2023 | 5 | 2023 |
| Germline alterations among Hispanic men with prostate cancer E Pan, J Shaya, L Madlensky, JM Randall, J Javier-Desloges, FE Millard, ... Prostate Cancer and Prostatic Diseases 25 (3), 561-567, 2022 | 5 | 2022 |
| Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy J Panian, A Saidian, K Hakimi, A Ajmera, WJ Anderson, P Barata, S Berg, ... The Oncologist, oyad166, 2023 | 4 | 2023 |
| Pathologic outcomes at cytoreductive nephrectomy (CN) following immunotherapy (IO) for patients with advanced renal cell carcinoma (RCC). J Panian, A Saidian, K Hakimi, A Ajmera, PC Barata, SA Berg, SL Chang, ... Journal of Clinical Oncology 40 (6_suppl), 334-334, 2022 | 2 | 2022 |
| Outcomes with novel combinations in non-clear cell renal cell carcinoma (nccRCC): ORACLE study. D Kilari, A Szabo, P Ghatalia, TL Rose, N Weise, MD Tucker, AA Nelson, ... Journal of Clinical Oncology 39 (15_suppl), 4580-4580, 2021 | 2 | 2021 |
| Germline alterations among Hispanic men with prostate cancer. J Shaya, SM Nielsen, KE Hatchell, ED Esplin, RL Nussbaum, N Weise, ... Journal of Clinical Oncology 39 (15_suppl), 10534-10534, 2021 | 2 | 2021 |
| Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy D Urman, L Deshler, N Weise, A Shabaik, I Derweesh, A Bagrodia, ... Clinical Genitourinary Cancer 21 (6), 660-668. e1, 2023 | 1 | 2023 |
| Outcomes with novel combinations in nonclear cell renal cell carcinoma (nccRCC): ORACLE study. D Kilari, A Szabo, P Ghatalia, TL Rose, H Dong, N Weise, TZ Zhuang, ... Journal of Clinical Oncology 40 (16_suppl), 4545-4545, 2022 | 1 | 2022 |
| Impact of neoadjuvant immune checkpoint inhibitor therapy on primary tumor size and complexity: Correlation with surgical quality and short term oncological outcomes. A Saidian, K Hakimi, J Panian, A Ajmera, PC Barata, SA Berg, SL Chang, ... Journal of Clinical Oncology 40 (6_suppl), 390-390, 2022 | 1 | 2022 |
| Treatment outcomes in renal cell carcinoma patients with metastases to the pancreas and other sites. C Duarte, B Beuselinck, N Weise, N Dizman, K Collier, H Li, ... Journal of Clinical Oncology 39 (15_suppl), 4557-4557, 2021 | 1 | 2021 |
| Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis K Hakimi, A Saidian, J Panian, P Barata, S Berg, SL Chang, RM Saliby, ... Clinical Genitourinary Cancer, 2023 | | 2023 |
| PD24-04 OUTCOMES OF DEFERRED CYTOREDUCTIVE NEPHRECTOMY FOLLOWING PRIMARY IMMUNOTHERAPY IN ADVANCED RENAL CELL CARCINOMA: A MULTICENTER ANALYSIS K Hakimi, A Saidian, J Panian, P Barata, S Berg, S Chang, R Saliby, ... The Journal of Urology 209 (Supplement 4), e722, 2023 | | 2023 |
| Germline alterations among Hispanic men with prostate cancer (April, 10.1038/s41391-022-00539-0, 2022) E Pan, J Shaya, L Madlensky, JM Randall, J Javier-Desloges, FE Millard, ... PROSTATE CANCER AND PROSTATIC DISEASES 25 (3), 599-599, 2022 | | 2022 |
| Correction: Germline alterations among Hispanic men with prostate cancer E Pan, J Shaya, L Madlensky, JM Randall, J Javier-Desloges, FE Millard, ... Prostate cancer and prostatic diseases 25 (3), 599, 2022 | | 2022 |
| 683P Impact of renin-angiotensin system inhibitors (RASi) on outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) PV Nuzzo, E Adib, N Weise, C Curran, T Stewart, D Freeman, AH Nassar, ... Annals of Oncology 32, S702-S703, 2021 | | 2021 |
| Survival outcomes of metastatic renal cell carcinoma (RCC) patients with pancreatic metastases (PM): Pooled analysis from a large clinical trials database. J Shaya, X Lin, A Cabal, J Panian, N Weise, RR McKay Journal of Clinical Oncology 38 (15_suppl), e17072-e17072, 2020 | | 2020 |
